Stock Events

Stock Events

Indivior Pharmaceuticals 

$38.20
68
-$0.28-0.73% Today

Statistics

Day High
38.94
Day Low
37.79
52W High
41
52W Low
13.45
Volume
48,065,852
Avg. Volume
-
Mkt Cap
4.78B
P/E Ratio
19.29
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 16
$0.10
Oct 15
$0.04
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

30JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
0.22
0.47
0.71
0.96
Expected EPS
0.88
Actual EPS
N/A

Financials

16.95%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
2.48BRevenue
420MNet Income

Analyst Ratings

48.00Average Price Target
The highest estimate is 48.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INDV. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.32B
Teva Pharmaceutical Industries manufactures generic drugs, including those for opioid addiction treatment, directly competing with Indivior's products.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its Janssen Pharmaceuticals division, offers products that compete in the opioid addiction treatment market.
Alkermes
ALKS
Mkt Cap7.08B
Alkermes plc provides addiction treatment products, including those for opioid dependence, which competes with Indivior's offerings.
DaVita
DVA
Mkt Cap13.39B
Dr. Reddy's Laboratories produces generic medication, including those for opioid addiction, competing with Indivior's Suboxone.
Novartis
NVS
Mkt Cap292.07B
Novartis AG, through its Sandoz division, offers generic versions of drugs that compete with Indivior's addiction treatment products.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. has a portfolio of drugs that can be used in the treatment of addiction, potentially competing with Indivior's products.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie Inc. engages in the development of pharmaceuticals that could compete with Indivior's treatments for opioid dependence.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. has a diverse drug portfolio that could include treatments competing with Indivior's addiction therapy products.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol-Myers Squibb Company offers a range of pharmaceutical products that may compete with Indivior's opioid addiction treatments.

About

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Show more...
CEO
Mr. Joseph J. Ciaffoni
Employees
1030
Country
United Kingdom
ISIN
US45579U1097

Listings

BOATS
BOATS
INDV.BOATS
XNAS
US
INDV

0 Comments

Share your thoughts

FAQ

What is Indivior Pharmaceuticals stock price today?▼
The current price of INDV is $38.20 USD — it has decreased by -0.73% in the past 24 hours. Watch Indivior Pharmaceuticals stock price performance more closely on the chart.
What is Indivior Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Indivior Pharmaceuticals stocks are traded under the ticker INDV.
Is Indivior Pharmaceuticals stock price growing?▼
INDV stock has risen by +2.06% compared to the previous week, the month change is a +3.81% rise, over the last year Indivior Pharmaceuticals has showed a +174.73% increase.
What is Indivior Pharmaceuticals market cap?▼
Today Indivior Pharmaceuticals has the market capitalization of 4.78B
When is the next Indivior Pharmaceuticals earnings date?▼
Indivior Pharmaceuticals is going to release the next earnings report on July 30, 2026.
What were Indivior Pharmaceuticals earnings last quarter?▼
INDV earnings for the last quarter are 0.96 USD per share, whereas the estimation was 0.66 USD resulting in a +45.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Indivior Pharmaceuticals revenue for the last year?▼
Indivior Pharmaceuticals revenue for the last year amounts to 2.48B USD.
What is Indivior Pharmaceuticals net income for the last year?▼
INDV net income for the last year is 420M USD.
Does Indivior Pharmaceuticals pay dividends?▼
Yes, INDV dividends are paid semi-annual. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Indivior Pharmaceuticals have?▼
As of June 15, 2026, the company has 1,030 employees.
In which sector is Indivior Pharmaceuticals located?▼
Indivior Pharmaceuticals operates in the Health & Wellness sector.
When did Indivior Pharmaceuticals complete a stock split?▼
Indivior Pharmaceuticals has not had any recent stock splits.
Where is Indivior Pharmaceuticals headquartered?▼
Indivior Pharmaceuticals is headquartered in North Chesterfield, United Kingdom.